
Sterile vials and prefilled syringes are often taken for granted in mainstream media, but pharma insiders know this is a challenging sector. Established contract manufacturers continue innovating to increase process efficiency and safety – through lyophilization, high-concentration formulations, prefilled syringes, ampoules, cartridges, pens, and more – while a slew of new entrants learn from the masters. State-sponsored efforts around the globe to diversify economies and enhance domestic drug supply have resulted in many new contractors entering the market. Add in the oversized impact of GLP-1 therapeutic popularity, and you have one of the most competitive niches of the market.


